Literature DB >> 23487448

Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice.

Kristin M Long1, Alan C Whitmore, Martin T Ferris, Gregory D Sempowski, Charles McGee, Bianca Trollinger, Bronwyn Gunn, Mark T Heise.   

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus responsible for recent epidemic outbreaks of debilitating disease in humans. Alphaviruses are known to interact with members of the C-type lectin receptor family of pattern recognition proteins, and given that the dendritic cell immunoreceptor (DCIR) is known to act as a negative regulator of the host inflammatory response and has previously been associated with rheumatoid arthritis, we evaluated DCIR's role in response to CHIKV infection. Although we observed an increase in the proportion of dendritic cells at the site of CHIKV infection at 24 to 36 h postinfection, these cells showed decreased cell surface DCIR, suggestive of DCIR triggering and internalization. In vitro, bone marrow-derived dendritic cells from DCIR-deficient (DCIR(-/-)) mice exhibited altered cytokine expression following exposure to CHIKV. DCIR(-/-) mice exhibited more severe disease signs than wild-type C57BL6/J mice following CHIKV infection, including a more rapid and more severe onset of virus-induced edema and enhanced weight loss. Histological examination revealed that DCIR-deficient animals exhibited increased inflammation and damage in both the fascia of the inoculated foot and the ankle joint, and DCIR deficiency skewed the CHIKV-induced cytokine response at the site of infection at multiple times postinfection. Early differences in virus-induced disease between C57BL6/J and DCIR(-/-) mice were independent of viral replication, while extended viral replication correlated with enhanced foot swelling and tissue inflammation and damage in DCIR(-/-) compared to C57BL6/J mice at 6 to 7 days postinfection. These results suggest that DCIR plays a protective role in limiting the CHIKV-induced inflammatory response and subsequent tissue and joint damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23487448      PMCID: PMC3648201          DOI: 10.1128/JVI.01611-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features.

Authors:  M C ROBINSON
Journal:  Trans R Soc Trop Med Hyg       Date:  1955-01       Impact factor: 2.184

2.  DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif.

Authors:  Nobuo Kanazawa; Taku Okazaki; Hiroyuki Nishimura; Kei Tashiro; Kayo Inaba; Yoshiki Miyachi
Journal:  J Invest Dermatol       Date:  2002-02       Impact factor: 8.551

3.  T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery.

Authors:  J S Serody; E J Collins; R M Tisch; J J Kuhns; J A Frelinger
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

4.  Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.

Authors:  L J White; J G Wang; N L Davis; R E Johnston
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 5.  Ross River virus transmission, infection, and disease: a cross-disciplinary review.

Authors:  D Harley; A Sleigh; S Ritchie
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice.

Authors:  B A Lidbury; C Simeonovic; G E Maxwell; I D Marshall; A J Hapel
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  Cloning and characterization of a novel ITIM containing lectin-like immunoreceptor LLIR and its two transmembrane region deletion variants.

Authors:  X Huang; Z Yuan; G Chen; M Zhang; W Zhang; Y Yu; X Cao
Journal:  Biochem Biophys Res Commun       Date:  2001-02-16       Impact factor: 3.575

8.  Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability.

Authors:  P W Hamer; J M McGeachie; M J Davies; M D Grounds
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

9.  The ITIM-bearing CLECSF6 (DCIR) is down-modulated in neutrophils by neutrophil activating agents.

Authors:  Manon Richard; Nathalie Thibault; Patricia Veilleux; Rock Breton; André D Beaulieu
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

10.  A replication study confirms the association of dendritic cell immunoreceptor (DCIR) polymorphisms with ACPA - negative RA in a large Asian cohort.

Authors:  Jianping Guo; Xinyu Wu; Chun Lai Too; Fangrui Yin; Xiaolan Lu; Jing He; Ru Li; Xu Liu; Shahnaz Murad; Leonid Padyukov; Zhanguo Li
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

View more
  24 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease.

Authors:  Clare E Bryant; Selinda Orr; Brian Ferguson; Martyn F Symmons; Joseph P Boyle; Tom P Monie
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

2.  Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.

Authors:  Kristen M Feibelman; Benjamin P Fuller; Linfeng Li; Daniel V LaBarbera; Brian J Geiss
Journal:  Antiviral Res       Date:  2018-04-20       Impact factor: 5.970

Review 3.  Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors.

Authors:  Salvador Iborra; David Sancho
Journal:  Immunobiology       Date:  2014-09-16       Impact factor: 3.144

4.  γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease.

Authors:  Kristin M Long; Martin T Ferris; Alan C Whitmore; Stephanie A Montgomery; Lance R Thurlow; Charles E McGee; Carlos A Rodriguez; Jean K Lim; Mark T Heise
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

5.  Protective and Pathogenic Responses to Chikungunya Virus Infection.

Authors:  Kristin M Long; Mark T Heise
Journal:  Curr Trop Med Rep       Date:  2015-03

6.  Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.

Authors:  Pankaj Pal; Julie M Fox; David W Hawman; Yan-Jang S Huang; Ilhem Messaoudi; Craig Kreklywich; Michael Denton; Alfred W Legasse; Patricia P Smith; Syd Johnson; Michael K Axthelm; Dana L Vanlandingham; Daniel N Streblow; Stephen Higgs; Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

7.  Phenotypic and Kinetic Changes of Myeloid Lineage Cells in Innate Response to Chikungunya Infection in Cynomolgus Macaques.

Authors:  Brandon J Beddingfield; Chie Sugimoto; Eryu Wang; Scott C Weaver; Kasi E Russell-Lodrigue; Stephanie Z Killeen; Marcelo J Kuroda; Chad J Roy
Journal:  Viral Immunol       Date:  2022-03-25       Impact factor: 2.175

Review 8.  Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.

Authors:  Mareike K S van Duijl-Richter; Tabitha E Hoornweg; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  Viruses       Date:  2015-07-07       Impact factor: 5.048

Review 9.  Signalling C-type lectin receptors, microbial recognition and immunity.

Authors:  J Claire Hoving; Gillian J Wilson; Gordon D Brown
Journal:  Cell Microbiol       Date:  2014-01-10       Impact factor: 3.715

10.  Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention.

Authors:  Yang Liu; Fuchun Zhang; Jianying Liu; Xiaoping Xiao; Siyin Zhang; Chengfeng Qin; Ye Xiang; Penghua Wang; Gong Cheng
Journal:  PLoS Pathog       Date:  2014-02-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.